Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-05-10 to 2025-11-09
Current total value of award: $2475623
Description: TO DEVELOP A NOVEL MODULATOR TARGETING PROTEOSTASIS FOR THE TREATMENT OF M. TUBERCULOSIS.